108 related articles for article (PubMed ID: 31178298)
1. Blast from the past: Perioperative use of the Maruyama computer program for prediction of lymph node involvement in the surgical treatment of gastric cancer following neoadjuvant chemotherapy.
Rawicz-Pruszyński K; Mielko J; Ciseł B; Skórzewska M; Pikuła A; Gęca K; Skoczylas T; Kubiatowski T; Kurylcio A; Polkowski WP
Eur J Surg Oncol; 2019 Oct; 45(10):1957-1963. PubMed ID: 31178298
[TBL] [Abstract][Full Text] [Related]
2. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
3. [Role of a computer program in gastric cancer surgery - beyond the evidence].
Tóth D; Bíró A; Kincses Z; Árkosy P; Török M
Magy Seb; 2017 Mar; 70(1):48-55. PubMed ID: 28294665
[TBL] [Abstract][Full Text] [Related]
4. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
6. A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT.
Hasegawa S; Yoshikawa T; Shirai J; Fujikawa H; Cho H; Doiuchi T; Yoshida T; Sato T; Oshima T; Yukawa N; Rino Y; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Jun; 20(6):2016-22. PubMed ID: 23266583
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
Lin JX; Yoon C; Desiderio J; Yi BC; Li P; Zheng CH; Parisi A; Huang CM; Strong VE; Yoon SS
Br J Surg; 2019 Aug; 106(9):1187-1196. PubMed ID: 31197829
[TBL] [Abstract][Full Text] [Related]
8. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
9. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer.
Guadagni S; de Manzoni G; Catarci M; Valenti M; Amicucci G; De Bernardinis G; Cordiano C; Carboni M; Maruyama K
World J Surg; 2000 Dec; 24(12):1550-8. PubMed ID: 11193722
[TBL] [Abstract][Full Text] [Related]
12. Preoperative prediction of lymph node status in gastric cancer patients with the help of computer analysis.
Mekicar J; Omejc M
Dig Surg; 2009; 26(3):256-61. PubMed ID: 19590202
[TBL] [Abstract][Full Text] [Related]
13. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
14. Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study.
Bollschweiler EH; Mönig SP; Hensler K; Baldus SE; Maruyama K; Hölscher AH
Ann Surg Oncol; 2004 May; 11(5):506-11. PubMed ID: 15123460
[TBL] [Abstract][Full Text] [Related]
15. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
[TBL] [Abstract][Full Text] [Related]
16. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
18. [Study on the sensitivity of multi-slice spiral CT in diagnosis of lymph node metastasis in different lymph node stations of gastric cancer].
Xu SH; Feng LL; Chen YM; Zhang R
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):984-989. PubMed ID: 31630498
[No Abstract] [Full Text] [Related]
19. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study.
Mokadem I; Dijksterhuis WPM; van Putten M; Heuthorst L; de Vos-Geelen JM; Haj Mohammad N; Nieuwenhuijzen GAP; van Laarhoven HWM; Verhoeven RHA
Gastric Cancer; 2019 Nov; 22(6):1263-1273. PubMed ID: 30949777
[TBL] [Abstract][Full Text] [Related]
20. Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer.
Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; Charruf AZ; de Castria TB; Zilberstein B; Ceconello I; Avancini Ferreira Alves V; Ribeiro U; de Mello ES
J Surg Oncol; 2020 Apr; 121(5):795-803. PubMed ID: 31773740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
